L&C BIO Co.,LTD (KOSDAQ:290650)

South Korea flag South Korea · Delayed Price · Currency is KRW
55,200
+600 (1.10%)
Nov 20, 2025, 3:30 PM KST
1.10%
Market Cap1.34T
Revenue (ttm)75.98B
Net Income (ttm)124.29B
Shares Out24.62M
EPS (ttm)4,923.41
PE Ratio10.95
Forward PE4,135.97
Dividend50.00 (0.09%)
Ex-Dividend DateDec 29, 2025
Volume360,101
Average Volume597,522
Open54,100
Previous Close54,600
Day's Range53,300 - 55,500
52-Week Range15,640 - 67,900
Beta1.10
RSI54.81
Earnings DateNov 14, 2025

About L&C BIO Co.,LTD

L&C Bio Co., Ltd operates as a research and development company in tissue regeneration medicine. It offers human tissue, medical device, and cosmetics products. The company was founded in 2011 and is headquartered in Seongnam-si, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2011
Employees 142
Stock Exchange KOSDAQ
Ticker Symbol 290650
Full Company Profile

Financial Performance

In 2024, L&C BIO Co.,LTD's revenue was 72.09 billion, an increase of 9.35% compared to the previous year's 65.93 billion. Earnings were 141.06 billion, an increase of 191.69%.

Financial Statements

News

There is no news available yet.